# Analysis of resistance mechanisms to abivertinib, a third-generation EGFR tyrosine kinase inhibitor, in patients with EGFR T790M-positive non-small cell lung cancer from a phase I trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/analysis-of-resistance-mechanisms-to-abivertinib-a-third-generation-egfr/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Yichen Zhang,Zhihong Chen,Xu‐Chao Zhang,Chong‐Rui Xu,Hong‐Hong Yan,Zhi Xie,Shaokun Chuai,Junyi Ye,Han Han‐Zhang,Zhou Zhang,Xiaoyan Bai,Jian Su,Bin Gan,Jin‐Ji Yang,Wenfeng Li,Wei Tang,Feng Luo,Xiao Xu,Yi‐Long Wu,Qing Zhou |
| Citations | 46 |
| DOI | 10.1016/j.ebiom.2019.04.030 |
| Fields | Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | http://www.thelancet.com/article/S2352396419302695/pdf |
| OpenAlex ID | https://openalex.org/W2942402550 |
| PMID | 31027916 |
| Type | article |
| Year | 2019 |

## Paper authors

- [Xu‐Chao Zhang](https://scholariq.org/researchers/xu-chao-zhang/)
- [Zhi Xie](https://scholariq.org/researchers/zhi-xie/)
- [Xiao Xu](https://scholariq.org/researchers/xiao-xu/)
- [Yi‐Long Wu](https://scholariq.org/researchers/yi-long-wu/)
- [Qing Zhou](https://scholariq.org/researchers/qing-zhou/)

## Paper funders

- [Eli Lilly and Company](https://scholariq.org/funders/eli-lilly-and-company/)
- [Pfizer](https://scholariq.org/funders/pfizer/)
- [AstraZeneca](https://scholariq.org/funders/astrazeneca/)
- [Roche](https://scholariq.org/funders/roche/)
- [Sanofi](https://scholariq.org/funders/sanofi/)
- [National Key Research and Development Program of China](https://scholariq.org/funders/national-key-research-and-development-program-of-china/)

## Paper journal

- [EBioMedicine](https://scholariq.org/journals/ebiomedicine/)

## Paper primary topic

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

## Paper topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.